These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pseudoaldosteronism due to 9-alpha-fluoroprednisolone creams. Praga M; Maiz E; Mijares RP; Lopez de Novales E Clin Nephrol; 1983 Dec; 20(6):321. PubMed ID: 6641033 [No Abstract] [Full Text] [Related]
7. [Pseudohyperaldosteronism secondary to oral brushing of 9-alpha-fluoroprednisolone. Presentation of a clinical case]. Rosselli A; Calacoci S; Regoli G; Turchi A G Clin Med; 1985; 66(9-10):359-62. PubMed ID: 3833560 [No Abstract] [Full Text] [Related]
9. The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray. Funder JW; Adam WR; Mantero F; Kraft N; Ulick S J Clin Endocrinol Metab; 1979 Dec; 49(6):842-6. PubMed ID: 92477 [No Abstract] [Full Text] [Related]
10. Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. Vita G; Bartolone S; Santoro M; Toscano A; Carrozza G; Girlanda P; Frisina N Clin Neuropathol; 1987; 6(2):80-5. PubMed ID: 3594977 [TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension induced by an excess of mineralocorticoids caused by abuse of nasal spray. Report of a case]. De Venuto G; Mattarei M; Dal Piaz A; De Santa A; Torboli PL; Miori R Minerva Med; 1984 Jun; 75(27):1673-77. PubMed ID: 6205328 [TBL] [Abstract][Full Text] [Related]
12. Hypokalemic myopathy associated with intranasal steroid use (factitious mineralocorticoid excess syndrome. Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D; Bisbocci D J Neurol; 1982; 226(4):265-8. PubMed ID: 6174707 [No Abstract] [Full Text] [Related]
13. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone]. Virgolini L; Geatti O; Giunta G Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510 [No Abstract] [Full Text] [Related]
14. [Pseudo-hyperaldosteronism caused by intranasal instillation of 9-alpha-fluoro-prednisolone acetate. Clinico-pathogenetic considerations of a case]. Camici M; Cini G; Donadio C; Pentimone F Minerva Med; 1980 Mar; 71(8):563-6. PubMed ID: 7360385 [No Abstract] [Full Text] [Related]
15. Pseudoaldosteronism due to 9-alpha-fluoroprednisolone creams. Morán JM; De Sancho JL; Abaigar P; Amenabar J; Muñiz R; Lampreabe I Clin Nephrol; 1984 Dec; 22(6):323-4. PubMed ID: 6525775 [No Abstract] [Full Text] [Related]
16. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone]. Foresti V; Parisio E; Ricci G Minerva Med; 1987 Sep; 78(17):1305-11. PubMed ID: 2444906 [TBL] [Abstract][Full Text] [Related]
17. Pseudoprimary hyperaldosteronism from topical application of 9-alpha-fluorprednisolone on the skin. Brognoli M; Doregatti C; Roncali M; Orlandini G Clin Nephrol; 1985 Dec; 24(6):315-6. PubMed ID: 4075602 [No Abstract] [Full Text] [Related]
18. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone. Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277 [TBL] [Abstract][Full Text] [Related]